Patents by Inventor Svend Havelund

Svend Havelund has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4614730
    Abstract: Isulin solutions physically stabilized by presence of one or more phospholipids, preferably a lecithin. The phospholipid is present in concentration of 10-200 .mu.g/ml.
    Type: Grant
    Filed: July 31, 1984
    Date of Patent: September 30, 1986
    Assignee: Novo Industri A/S
    Inventors: Philip E. Hansen, Jens J. V. Brange, Svend Havelund
  • Patent number: 4476118
    Abstract: Novel pharmaceutical solutions of dissolved insulin having improved physical stability prepared by incorporating therein an essentially ionized zinc salt in a concentration corresponding to a content of zinc ions at the disposal of the insulin of more than 4 Zn.sup.2+ /hexamer insulin preferably 4.2-4.5 Zn.sup.2+ /hexamer insulin. The solutions exhibit a stability factor exceeding 5.The novel insulin solutions are particularly adapted for use in continuous insulin delivery equipment.
    Type: Grant
    Filed: February 4, 1983
    Date of Patent: October 9, 1984
    Assignee: Novo Industri A/S
    Inventors: Jens J. V. Brange, Svend Havelund
  • Patent number: 4472385
    Abstract: Novel pharmaceutical preparations of dissolved insulin having improved physical stability particularly adapted for use in continuous insulin delivery equipment prepared by incorporating therein a calcium or magnesium salt so as to provide a solution containing essentially ionized calcium or magnesium in insulin stabilizing concentrations.The magnesium or calcium ions concentrations are with the range of about 0.4.times.10.sup.-3 to 10.sup.-2 molar.
    Type: Grant
    Filed: March 9, 1982
    Date of Patent: September 18, 1984
    Assignee: Novo Industri A/S
    Inventors: Jens J. V. Brange, Svend Havelund